TREATMENT AND PROPHYLAXIS OF K. PNEUMONIAE INFECTION

The present invention relates to antibodies that target proteins derived from Klebsiella pneumoniae as well as therapeutic use of the antibodies. The antibodies bind specifically to the protein having SEQ ID NO: 18 (KP1_1632). Also disclosed is vaccines comprising material derived from SEQ ID NO: 18...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MØLLER, Niels Iversen, MATTSSON, Andreas Holm
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to antibodies that target proteins derived from Klebsiella pneumoniae as well as therapeutic use of the antibodies. The antibodies bind specifically to the protein having SEQ ID NO: 18 (KP1_1632). Also disclosed is vaccines comprising material derived from SEQ ID NO: 18.